Kymera Therapeutics, Inc. · NASDAQ:KYMR
Goodman Noah sold 3,389 Kymera Therapeutics, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Goodman Noah (Chief Business Officer) sold 3,389 Kymera Therapeutics, Inc. shares at US$114.29 for US$387K under a trading plan, leaving 47,179 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 3,389 shares
- Price
- US$114.29
- Value
- US$387K
- Holding after
- 47,179 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Business Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Sale | 3,389 | US$114.29 | 47,179 | Direct |
Source
Related
- Kymera Therapeutics, Inc.
- Goodman Noah
- Kymera Therapeutics, Inc. shareholders
- Form 4 · Goodman Noah · Jun 25, 2026
- Form 4 · Goodman Noah · Jun 22, 2026
- Form 4 · Goodman Noah · Apr 16, 2026
- Form 4 · Goodman Noah · Apr 10, 2026
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026